MAIA Biotechnology, Inc.
  • About
    • About Us
    • Management
    • Board of Directors
    • Scientific Advisors
    • Advisors
    • Careers
  • Programs
    • Pipeline
    • Ateganosine (THIO) Program
    • Second-Generation Programs
    • Publications
  • Partners
  • Investors
  • Contact
  • Menu Menu
  • x
  • LinkedIn

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Analyst Coverage
    • Presentations
    • Contacts
    • FAQ
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 04, 2025 8:51am EST

MAIA Biotechnology Announces Positive Efficacy Updates for Phase 2 THIO-101 Trial in Advanced Non-Small Cell Lung Cancer

Jan 10, 2025 9:45am EST

MAIA Biotechnology to Present at Biotech Showcase 2025

Jan 07, 2025 9:12am EST

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications

Dec 19, 2024 8:47am EST

MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings

Dec 16, 2024 8:37am EST

MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas

Dec 09, 2024 6:00pm EST

MAIA Biotechnology Announces Private Placement of Approximately $950,000

Dec 03, 2024 8:17am EST

MAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung Cancer

Nov 07, 2024 8:47am EST

MAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private Placement

Nov 05, 2024 9:45am EST

MAIA Biotechnology Announces Late-Breaking Abstract of THIO-101 Updates Selected for Oral and Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting

Oct 28, 2024 7:00pm EDT

MAIA Biotechnology Announces $2.44 Million Private Placement

  • arrow_back
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …11
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© Copyright 2025 - MAIA Biotechnology, Inc.     312.416.8592     |     info@maiabiotech.com     |     Terms of Use    |     Privacy Policy    |     Cookies Policy